Stereotactic body radiotherapy for poor-risk lung cancer: "more cyber, less knife?"

Cancer Journal

Volumn 13, Issue 2, 2007, Pages 75-77

  Bogart, Jeffrey A ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CRYOTHERAPY; LUNG NON SMALL CELL CANCER; NOTE; PRIORITY JOURNAL; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; LUNG TUMOR; MORTALITY; PATHOLOGY; RADIATION DOSE FRACTIONATION; RADIOSURGERY; ROBOTICS;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; ROBOTICS;

EID: 34347241742     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3180465303     Document Type: Note

References (14)

1. McGarry RC, Song G, des Rosiers P, et al. Observation-only management of early stage, medically inoperable lung cancer. Chest. 2002;121: 1155-1158.
2. Kyasa MJ, Jazieh AR. Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer. South Med J. 2002; 95:1149-1152.
3. Henschke CI, Wisnevsky JP, Yankelevitz DF, et al. Small stage I cancers of the lung: genuineness and curability. Lung Cancer. 2003;39: 327-339.
4. Blomgren H, Lax I, Naslund I, et al. Stereotactic-high dose fraction radiation therapy of extracranial tumors using an accelerator: clinical experience of the first thirty-one patients. Acta Oncol. 1995;34:861-870.
5. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124:1946-1955.
6. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a Phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833-4839.
7. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung cancer: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623-1631.
8. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer: a retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45:787-795.
9. Hoyer M, Roed H, Hansen A, et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;66:s128-s135.
10. A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. RTOG 0236. Available at: http://rtog.org/summaries/lung. html. Accessed January 2, 2007.
11. Le QT, Loo BW, Ho A, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006;1:802-809.
12. Fujino M, Shirato H. Onishi H, et al. Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereo-tactic irradiation for lung tumors. Cancer J. 2006;12:41-46.
13. Brown W, Wu X., Amendola B, et al. Treatment of early NSCLC, stage IA by image-guided robotic stereotactic radiotherapy-CyberKnife. Cancer J. 2007;13:87-94.
14. Timmerman R, Galvin J, Michalski J, et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol. 2006;45:779-786.